Central retinal vein occlusion – current treatment strategies

Article Sidebar

PDF (Język Polski)


Published: Jun 30, 2016
Keywords:
central retinal vein occlusion, ranizumab, aflibercept, bevacizumab, dexamethasone, mocular edema

Main Article Content

Paulina Glasner
Katedra i Klinika Okulistyki, Gdański Uniwersytet Medyczny
Dorota Raczyńska
Katedra i Klinika Okulistyki, Gdański Uniwersytet Medyczny
Leopold Glasner
Katedra i Klinika Okulistyki, Gdański Uniwersytet Medyczny

Abstract

Retinal vein occlusion is one of the main reasons of low visual acuity in high- -developed countries. There was a lot of methods of treatment of the disease in the past, nevertheless, nowadays only a few are commonly used. In randomized, multi-centered research anti-VEGF treatment, steroid and laser photocoagulation effectiveness were proven. Anti-VEGF therapy seems to be the first choice drug in the last few years.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Glasner P, Raczyńska D, Glasner L. Central retinal vein occlusion – current treatment strategies. Ophthatherapy [Internet]. 2016Jun.30 [cited 2024Nov.22];3(2):87-2. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/597
Issue
Vol 3 No 2 (2016)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res. 2005; 24(4): 493-519.
2. Kański JJ. Okulistyka kliniczna. Elsevier, Wrocław 2009: 627-33.
3. Niżankowska MH. Okulistyka. PZWL, Warszawa 2007: 442-7.
4. Hayreh SS, Zimmerman MB. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses. Retina. 2014; 34(1): 115-22.
5. Gawrońska P. Zakrzep gałązki żyły środkowej siatkówki – aktualności diagnostyczne i postępy w terapii. Przegląd Okulistyczny. 2007; 5(19): 8-9.
6. Wytyczne Polskiego Towarzystwa Okulistycznego leczenia obrzęku plamki wtórnego do niedrożności naczyń żylnych siatkówki. http://pto.com.pl/uploads/guidelines/10/files/Wytyczne-PTO-CRVO_BRVO.pdf.
7. Shah GK. Treatment of Retinal Vein Occlusion. Retina. 2012; 3: 70-1.
8. Narayanan R, Panchal B, Stewart MW et al. Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2. Clin Ophthalmol. 2016; 10: 1023-9.
9. Michalska-Małecka K, Gaborek A, Nowak M et al. Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion. Clin Interv Aging. 2016; 11: 699-705.
10. Wytyczne leczenia zakrzepu żyły środkowej siatkówki Brytyjskiego Królewskiego Towarzystwa Okulistycznego (The Royal College of Ophthalmologists) 2015 r. https://www.rcophth.ac.uk/wp-content/uploads/2015/07/Retinal-Vein-Occlusion-RVO-Guidelines-July-2015.pdf.
11. McAllister IL, Smithies LA, Previn V. Technique of laser chorioretinal anastomosis creation in central retinal vein occlusion and success rate with a new photocoagulator system. Retina. 2016 Mar 16 [Epub ahead of print].
12. Wang F, Zhang P, Sun X. [The role of laser photocoagulation in the anti-vascular endothelial growth factor therapy era]. Zhonghua Yan Ke Za Zhi. 2015; 51(12): 885-7.
13. Wang MD, Jeng-Miller KW, Feng HL, et al. Retina specialists treating cystoid macular oedema secondary to retinal vein occlusion recommend different treatments for patients than they would choose for themselves. Br J Ophthalmol. 2015 Dec 30. https://doi.org/10.1136/bjophthalmol-2015-307849.